cemka > Publications > Cardiologie

Classer les publications sur l'année

  • Pharmaco-EpidĂ©miologie

    Epidémiologie de la maladie thromboembolique veineuse

    BENARD E, LAFUMA A, RAVAUD P

    Presse Med ; 2005;34(6):415-419

  • Pharmaco-EpidĂ©miologie

    Prise en charge de l’insuffisance cardiaque sĂ©vĂšre dans l’Ă©tude EPICAL en Lorraine

    FAGNANI F, BUTEAU L, VIRION JM, BRIANCON S, ZANNAD F

    Thérapie ; 2001;56(1): 5-10

  • Pharmaco-EpidĂ©miologie

    Pregnancy-induced changes in lower extremity superficial veins: an ultrasound scan study

    BOIVIN P, CORNU-THENARD A, CHARPAK Y

    J Vasc Surg ; 2000;32:570-574

  • Pharmaco-EpidĂ©miologie

    EpidĂ©miologie de l’insuffisance cardiaque en France : approche mĂ©dico-Ă©conomique

    FAGNANI F

    La Lettre du Cardiologue 1er Trimestre 2000 ; IV-VI

  • Économie de la santĂ©

    Economic evaluation of enoxaparin versus heparin in unstable angina: a French sub-study of the ESSENCE trial

    DETOURNAY B, HUET X, FAGNANI F, MONTALESCOT G

    PharmacoEconomics ; 2000;18(1):83-89

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Outcomes and management costs of peripheral artery disease in France

    BURA RIVIERE A, BOUEE S, LAURENDEAU C, TORRETON E, GOURMELEN J, THOMAS-DELECOURT F.

    J Vasc Surg ; 2018;67(6):1834-1843

  • Autres

    DEPIVIH 2: Use of three HIV testing methods in French primary care settings – ELISA laboratory screening versus two rapid point-of-care HIV tests.

    PAPADIMA D, GAUTHIER R, PREVOTEAU DU CLARY F, BOUEE S, CONORT G, LIVROZET JM, TAULERA O, WAJSBROT A, MAJERHOLC C, PETER JM, AUBERT JP

    Med Mal Infect ; 2018;48(2018):122-129

  • Économie de la santĂ©

    ConsĂ©quences Ă©conomiques du suivi biologique et des complications mĂ©dicales en lien avec l’utilisation des anticoagulants injectables en France.

    PAUBEL P, COUSIN M, AMAR C, GOURMELEN  J, FABRON C, DETOURNAY B

    J Mal Vasc ; 2016;41:371-377

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Outcomes following acute hospitalised myocardial infarction in France: An insurance claims database analysis

    BLIN P, PHILIPPE F, BOUEE S, LAURENDEAU C, TORRETON E, GOURMELIN J, LEPROUST S , LEVY-BACHELOT L, STEG PG

    Int J Cardiol ; 2016;219:387-393

  • Pharmaco-EpidĂ©miologie

    Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.

    BOUEE S, EMERY C, SAMSON A, GOURMELEN J, BAILLY C, COTTE FE.

    Thromb J. ; 2016;14(4)

  • Pharmaco-EpidĂ©miologie

    Incidence of Cardiovascular Events Following Myocardial Infarction in France: an Observational Analysis Using a Claims Database.

    PHILIPPE F, BLIN P, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.

    Value Health ; 2015;18(7):A382

  • Économie de la santĂ©

    Increased Costs Due To Myocardial Infarction (Mi) In France: An Observational Analysis Using A Claims Database.

    BLIN P, PHILIPPE F, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.

    Value Health ; 2015;18(7):A386

  • Pharmaco-EpidĂ©miologie

    Characteristics and management of outpatients with history of or current atrial fibrillation : the observational French EPHA study

    COHEN A, DALLONGEVILLE J, DURAND-ZALESKI I, BOUÉE S, LE HEUZEY JY, the EPHA Investigators

    Arch Cardiovasc Dis ; 2010;103(6-7):376-387

  • Pharmaco-EpidĂ©miologie

    Epidemiology of atrial fibrillation in France : extrapolation of international epidemiological data to France and analysis of french hospitalization data

    CHARLEMAGNE A, BLACHER J, COHEN A, COLLET JP, DIEVART F, DE GROOTE P, HANON O, LEENARDT A, PINEL JF, PISICA-DONOSE G, LE HEUZEY JY

    Arch Cardiovasc Dis ; 2011;104:115-124

  • Économie de la santĂ©

    Long term treatment of atrial fibrillation in elderly patients: A decision analysis

    LAFUENTE C, EMERY C, LAURENDEAU C, FAGNANI F, BERGMANN JF

    Int J Cardiol ; 2012;155(1):102-109